Loading
Latest filing published 31 Jul 2026 for HCW Biologics Inc., €53k. Read the official filing
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of Hing C. Wong in HCW Biologics Inc. We count 16 filings; the first trade dates from 22 July 2021 and the latest from 29 July 2026.
No open-market sale appears; the market trades are 14 purchases worth €2.4M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant. Since January 2026: 1 purchase and no sales on the market.
A typical purchase (the median) is worth €12k. Clusters matter here: 14 out of 14 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
Most recently, on 31 July 2026, the filings show an open-market purchase worth €53k in HCW Biologics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations